Transforming Medicine Through Precision Epigenomic Control
Programmable mRNA Therapeutics
Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines for unprecedented control of gene regulation and cellular function. Through our OMEGA platform, we engineer mRNA therapeutics called Omega Epigenomic Controllers™ (OECs), with the goal of treating or curing a broad range of diseases in the service of patients.
With computational genomics, machine learning, and artificial intelligence systems driving our OMEGA platform, we combine foundational science, deterministic drug design and customized delivery options to rapidly and rationally design potentially life-changing medicines that control gene expression and cellular programming.
We’re advancing a robust pipeline, thoughtfully designed to demonstrate the ability of OECs to target diverse biology, tissue, and disease types, including previously elusive diseases.
A world-class team committed to keeping the unmet needs of patients at the center of everything we do.
“Ambitious yet humble” is our guiding ethos. As we grow, we continue to look for agile and resilient leaders, thinkers and scientists who strive to pursue the discovery and development of groundbreaking therapeutics.